Author(s): Aghaizu A, Mercey D, Copas A, Johnson AM, Hart G, , Aghaizu A, Mercey D, Copas A, Johnson AM, Hart G,
Abstract Share this page
Abstract OBJECTIVE: To assess current and intended future use of pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) and characterise those attending sexual health clinics, the anticipated PrEP delivery setting. DESIGN: Cross-sectional study. METHODS: Self-administered survey of 842 HIV negative MSM recruited from social venues in London in 2011. RESULTS: One in 10 (10.2\%, 83/814, 95\% CI 8.2\% to 12.5\%) and one in 50 (2.1\%, 17/809, 95\% CI 1.2\% to 3.3\%) reported having ever used post-exposure prophylaxis (PEP) and PrEP respectively. Half reported they would be likely to use PrEP if it became available as a daily pill (50.3\%, 386/786, 95\% CI 46.7\% to 53.9\%). MSM were more likely to consider future PrEP use if they were <35 years (adjusted OR (AOR) 1.57, 95\% CI 1.16 to 2.14), had unprotected anal intercourse with casual partners (AOR 1.70, 95\% CI 1.13 to 2.56), and had previously used PEP (AOR 1.94, 95\% CI 1.17 to 3.24). Over half of MSM (54.8\% 457/834 95\% CI 51.3 to 58.2) attended a sexual health clinic the previous year. Independent factors associated with attendance were age <35 (AOR 2.29, 95\% CI 1.68 to 3.13), and ≥ 10 anal sex partners in the last year (AOR 2.49, 95\% CI 1.77 to 3.52). CONCLUSIONS: The concept of PrEP for HIV prevention in the form of a daily pill is acceptable to half of sexually active MSM in London. MSM reporting higher risk behaviours attend sexual health clinics suggesting this is a suitable setting for PrEP delivery.
This article was published in Sex Transm Infect
and referenced in Journal of AIDS & Clinical Research